Insulin detemir and Mogamulizumab-kpkc Intravenous
Determining the interaction of Insulin detemir and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin Detemir
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir-Molindone
- Insulin detemir-Mometasone (Oral Inhalation)
- Insulin detemir-Mometasone and Formoterol
- Insulin detemir-Mometasone and formoterol Inhalation
- Insulin detemir-Mometasone Cream
- Insulin detemir-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Mogamulizumab-kpkc Intravenous-Insulin Detemir (Vials)
- Mogamulizumab-kpkc Intravenous-Insulin detemir Subcutaneous
- Mogamulizumab-kpkc Intravenous-Insulin glargine
- Mogamulizumab-kpkc Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Mogamulizumab-kpkc Intravenous-Insulin Glargine (U-100) Vials